•
Sep 30, 2023

Sagimet Biosciences Q3 2023 Earnings Report

Total Revenue
$2M
EPS
-$0.35
Previous year: $6.69K
-100.0%
Gross Profit
$1.97M
Cash and Equivalents
$102M
Previous year: $2.23M
+4466.9%
Free Cash Flow
-$3.88M
Total Assets
$103M

Sagimet Biosciences

Sagimet Biosciences